Optimizing the removal of an STmp protecting group
Small Molecules and Synthetic Therapeutics
Read our blog to learn more about one protection strategy that can be used for these compounds.
Small Molecules and Synthetic Therapeutics
Read our blog to learn more about one protection strategy that can be used for these compounds.
Small Molecules and Synthetic Therapeutics
Green chemistry solutions are highly desirable. Read more to learn about greener solvent alternatives to DMF and NMP for peptide synthesis.
Small Molecules and Synthetic Therapeutics
Flow rate affects both selectivity and resolution. Read more to help determine which flow rate works best for purifying peptides with flash ...
Small Molecules and Synthetic Therapeutics
Amino acids can account for a significant fraction of the total cost for peptide synthesis. Read more to learn how many equivalents you can ...
Small Molecules and Synthetic Therapeutics
Fully automating synthesis and secondary chemistry is always desirable, unless it comes at a cost of yield or purity. Read more for ...
Small Molecules and Synthetic Therapeutics
Particle size and pore size can both impact resolution, but especially when using reversed phase flash chromatography. Read more to see ...
Small Molecules and Synthetic Therapeutics
The articles contains an interview to Richard E. Johnsson, Ph.D., Head of Peptide Chemistry at Red Glead Discovery, Lund, Sweden, who ...
Small Molecules and Synthetic Therapeutics
The number of equivalents used in a synthesis can significantly impact the cost of a peptide synthesis. Read more to learn how few ...
Small Molecules and Synthetic Therapeutics
Aspartimide rearrangements can negatively impact biological screening outcomes. Read more to learn methods to identify this side reaction ...
Small Molecules and Synthetic Therapeutics
Aspartimide rearrangements are one of the most ubiquitous side reactions encountered during solid phase synthesis. Read more to learn how ...